The antiinflammatory activity of topically applied novel calcium-channel antagonists
The antiinflammatory activities of two novel calcium-channel antagonists, AGN 190742 and AGN 190744, were evaluated in murine models of cutaneous inflammation. These 2(5H)-furanone ring compounds block both depolarization-dependent Ca2+ entry and receptor-mediated responses in GH3 cells. Topical app...
Gespeichert in:
| Veröffentlicht in: | Inflammation 1995-04, Vol.19 (2), p.261-275 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 275 |
|---|---|
| container_issue | 2 |
| container_start_page | 261 |
| container_title | Inflammation |
| container_volume | 19 |
| creator | De Vries, G W McLaughlin, A Wenzel, M B Perez, J Harcourt, D Lee, G Garst, M Wheeler, L A |
| description | The antiinflammatory activities of two novel calcium-channel antagonists, AGN 190742 and AGN 190744, were evaluated in murine models of cutaneous inflammation. These 2(5H)-furanone ring compounds block both depolarization-dependent Ca2+ entry and receptor-mediated responses in GH3 cells. Topical application of AGN 190742 or AGN 190744 inhibits neutrophil infiltration and epidermal hyperplasia induced by repeated treatment of mouse skin with phorbol ester. AGN 190744 also is active in an arachidonic acid model of acute inflammation. These data suggest that topical application of calcium-channel antagonists can inhibit cutaneous inflammatory responses and that AGN 190742 and/or AGN 190744 may serve as useful pharmacological probes for examining these responses in vivo. |
| doi_str_mv | 10.1007/BF01534466 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16837020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16837020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c313t-62e8c1a8691e687f7b64b8ce94c8dddd529f481123823d69a26eed47afaa26713</originalsourceid><addsrcrecordid>eNpFkDtPwzAUhS0EKqWwsCNlYkAK-JH4MUJFAakSS5kj17GpkWOH2KmUf49RK7jLvefou2c4AFwjeI8gZA9PK4hqUlWUnoA5qhkpcc3oKZhDQmFJhGDn4CLGLwghF5zMwIzR_AH5HGw2O11In6z1xsmukykMUyFVsnubpiKYIoXeKulcdvveWd0WPuy1K7Kn7NiVaie9zzqHyM_gbUzxEpwZ6aK-Ou4F-Fg9b5av5fr95W35uC4VQSSVFGuukORUIE05M2xLqy1XWlSKt3lqLEzFEcKEY9JSITHVuq2YNDKfDJEFuD3k9kP4HnVMTWej0s5Jr8MYG0Q5YRDDDN4dQDWEGAdtmn6wnRymBsHmt8Lmv8IM3xxTx22n2z_02Bn5AbKXbIY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16837020</pqid></control><display><type>article</type><title>The antiinflammatory activity of topically applied novel calcium-channel antagonists</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>De Vries, G W ; McLaughlin, A ; Wenzel, M B ; Perez, J ; Harcourt, D ; Lee, G ; Garst, M ; Wheeler, L A</creator><creatorcontrib>De Vries, G W ; McLaughlin, A ; Wenzel, M B ; Perez, J ; Harcourt, D ; Lee, G ; Garst, M ; Wheeler, L A</creatorcontrib><description>The antiinflammatory activities of two novel calcium-channel antagonists, AGN 190742 and AGN 190744, were evaluated in murine models of cutaneous inflammation. These 2(5H)-furanone ring compounds block both depolarization-dependent Ca2+ entry and receptor-mediated responses in GH3 cells. Topical application of AGN 190742 or AGN 190744 inhibits neutrophil infiltration and epidermal hyperplasia induced by repeated treatment of mouse skin with phorbol ester. AGN 190744 also is active in an arachidonic acid model of acute inflammation. These data suggest that topical application of calcium-channel antagonists can inhibit cutaneous inflammatory responses and that AGN 190742 and/or AGN 190744 may serve as useful pharmacological probes for examining these responses in vivo.</description><identifier>ISSN: 0360-3997</identifier><identifier>EISSN: 1573-2576</identifier><identifier>DOI: 10.1007/BF01534466</identifier><identifier>PMID: 7601508</identifier><language>eng</language><publisher>United States</publisher><subject><![CDATA[Administration, Cutaneous ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Arachidonic Acid - secretion ; Arachidonic Acid - toxicity ; Calcium - metabolism ; Calcium Channel Blockers - administration & dosage ; Calcium Channel Blockers - pharmacology ; Chemotaxis, Leukocyte - drug effects ; Clobetasol - analogs & derivatives ; Clobetasol - pharmacology ; Ear, External ; Epidermis - drug effects ; Epidermis - pathology ; Female ; Humans ; Hyperplasia ; Inflammation ; Mice ; Neutrophils - drug effects ; Neutrophils - enzymology ; Neutrophils - secretion ; Nifedipine - pharmacology ; Peroxidase - analysis ; Phosphatidylinositol Diacylglycerol-Lyase ; Phosphodiesterase Inhibitors - pharmacology ; Phospholipases A - antagonists & inhibitors ; Phosphoric Diester Hydrolases - metabolism ; Pituitary Neoplasms - pathology ; Potassium Chloride - antagonists & inhibitors ; Pyrazoles - pharmacology ; Terpenes - pharmacology ; Tetradecanoylphorbol Acetate - toxicity ; Thyrotropin-Releasing Hormone - antagonists & inhibitors ; Tumor Cells, Cultured - drug effects]]></subject><ispartof>Inflammation, 1995-04, Vol.19 (2), p.261-275</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c313t-62e8c1a8691e687f7b64b8ce94c8dddd529f481123823d69a26eed47afaa26713</citedby><cites>FETCH-LOGICAL-c313t-62e8c1a8691e687f7b64b8ce94c8dddd529f481123823d69a26eed47afaa26713</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7601508$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Vries, G W</creatorcontrib><creatorcontrib>McLaughlin, A</creatorcontrib><creatorcontrib>Wenzel, M B</creatorcontrib><creatorcontrib>Perez, J</creatorcontrib><creatorcontrib>Harcourt, D</creatorcontrib><creatorcontrib>Lee, G</creatorcontrib><creatorcontrib>Garst, M</creatorcontrib><creatorcontrib>Wheeler, L A</creatorcontrib><title>The antiinflammatory activity of topically applied novel calcium-channel antagonists</title><title>Inflammation</title><addtitle>Inflammation</addtitle><description>The antiinflammatory activities of two novel calcium-channel antagonists, AGN 190742 and AGN 190744, were evaluated in murine models of cutaneous inflammation. These 2(5H)-furanone ring compounds block both depolarization-dependent Ca2+ entry and receptor-mediated responses in GH3 cells. Topical application of AGN 190742 or AGN 190744 inhibits neutrophil infiltration and epidermal hyperplasia induced by repeated treatment of mouse skin with phorbol ester. AGN 190744 also is active in an arachidonic acid model of acute inflammation. These data suggest that topical application of calcium-channel antagonists can inhibit cutaneous inflammatory responses and that AGN 190742 and/or AGN 190744 may serve as useful pharmacological probes for examining these responses in vivo.</description><subject>Administration, Cutaneous</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Arachidonic Acid - secretion</subject><subject>Arachidonic Acid - toxicity</subject><subject>Calcium - metabolism</subject><subject>Calcium Channel Blockers - administration & dosage</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Chemotaxis, Leukocyte - drug effects</subject><subject>Clobetasol - analogs & derivatives</subject><subject>Clobetasol - pharmacology</subject><subject>Ear, External</subject><subject>Epidermis - drug effects</subject><subject>Epidermis - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperplasia</subject><subject>Inflammation</subject><subject>Mice</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - enzymology</subject><subject>Neutrophils - secretion</subject><subject>Nifedipine - pharmacology</subject><subject>Peroxidase - analysis</subject><subject>Phosphatidylinositol Diacylglycerol-Lyase</subject><subject>Phosphodiesterase Inhibitors - pharmacology</subject><subject>Phospholipases A - antagonists & inhibitors</subject><subject>Phosphoric Diester Hydrolases - metabolism</subject><subject>Pituitary Neoplasms - pathology</subject><subject>Potassium Chloride - antagonists & inhibitors</subject><subject>Pyrazoles - pharmacology</subject><subject>Terpenes - pharmacology</subject><subject>Tetradecanoylphorbol Acetate - toxicity</subject><subject>Thyrotropin-Releasing Hormone - antagonists & inhibitors</subject><subject>Tumor Cells, Cultured - drug effects</subject><issn>0360-3997</issn><issn>1573-2576</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDtPwzAUhS0EKqWwsCNlYkAK-JH4MUJFAakSS5kj17GpkWOH2KmUf49RK7jLvefou2c4AFwjeI8gZA9PK4hqUlWUnoA5qhkpcc3oKZhDQmFJhGDn4CLGLwghF5zMwIzR_AH5HGw2O11In6z1xsmukykMUyFVsnubpiKYIoXeKulcdvveWd0WPuy1K7Kn7NiVaie9zzqHyM_gbUzxEpwZ6aK-Ou4F-Fg9b5av5fr95W35uC4VQSSVFGuukORUIE05M2xLqy1XWlSKt3lqLEzFEcKEY9JSITHVuq2YNDKfDJEFuD3k9kP4HnVMTWej0s5Jr8MYG0Q5YRDDDN4dQDWEGAdtmn6wnRymBsHmt8Lmv8IM3xxTx22n2z_02Bn5AbKXbIY</recordid><startdate>19950401</startdate><enddate>19950401</enddate><creator>De Vries, G W</creator><creator>McLaughlin, A</creator><creator>Wenzel, M B</creator><creator>Perez, J</creator><creator>Harcourt, D</creator><creator>Lee, G</creator><creator>Garst, M</creator><creator>Wheeler, L A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>19950401</creationdate><title>The antiinflammatory activity of topically applied novel calcium-channel antagonists</title><author>De Vries, G W ; McLaughlin, A ; Wenzel, M B ; Perez, J ; Harcourt, D ; Lee, G ; Garst, M ; Wheeler, L A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c313t-62e8c1a8691e687f7b64b8ce94c8dddd529f481123823d69a26eed47afaa26713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Administration, Cutaneous</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - administration & dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Arachidonic Acid - secretion</topic><topic>Arachidonic Acid - toxicity</topic><topic>Calcium - metabolism</topic><topic>Calcium Channel Blockers - administration & dosage</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Chemotaxis, Leukocyte - drug effects</topic><topic>Clobetasol - analogs & derivatives</topic><topic>Clobetasol - pharmacology</topic><topic>Ear, External</topic><topic>Epidermis - drug effects</topic><topic>Epidermis - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperplasia</topic><topic>Inflammation</topic><topic>Mice</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - enzymology</topic><topic>Neutrophils - secretion</topic><topic>Nifedipine - pharmacology</topic><topic>Peroxidase - analysis</topic><topic>Phosphatidylinositol Diacylglycerol-Lyase</topic><topic>Phosphodiesterase Inhibitors - pharmacology</topic><topic>Phospholipases A - antagonists & inhibitors</topic><topic>Phosphoric Diester Hydrolases - metabolism</topic><topic>Pituitary Neoplasms - pathology</topic><topic>Potassium Chloride - antagonists & inhibitors</topic><topic>Pyrazoles - pharmacology</topic><topic>Terpenes - pharmacology</topic><topic>Tetradecanoylphorbol Acetate - toxicity</topic><topic>Thyrotropin-Releasing Hormone - antagonists & inhibitors</topic><topic>Tumor Cells, Cultured - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Vries, G W</creatorcontrib><creatorcontrib>McLaughlin, A</creatorcontrib><creatorcontrib>Wenzel, M B</creatorcontrib><creatorcontrib>Perez, J</creatorcontrib><creatorcontrib>Harcourt, D</creatorcontrib><creatorcontrib>Lee, G</creatorcontrib><creatorcontrib>Garst, M</creatorcontrib><creatorcontrib>Wheeler, L A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Vries, G W</au><au>McLaughlin, A</au><au>Wenzel, M B</au><au>Perez, J</au><au>Harcourt, D</au><au>Lee, G</au><au>Garst, M</au><au>Wheeler, L A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The antiinflammatory activity of topically applied novel calcium-channel antagonists</atitle><jtitle>Inflammation</jtitle><addtitle>Inflammation</addtitle><date>1995-04-01</date><risdate>1995</risdate><volume>19</volume><issue>2</issue><spage>261</spage><epage>275</epage><pages>261-275</pages><issn>0360-3997</issn><eissn>1573-2576</eissn><abstract>The antiinflammatory activities of two novel calcium-channel antagonists, AGN 190742 and AGN 190744, were evaluated in murine models of cutaneous inflammation. These 2(5H)-furanone ring compounds block both depolarization-dependent Ca2+ entry and receptor-mediated responses in GH3 cells. Topical application of AGN 190742 or AGN 190744 inhibits neutrophil infiltration and epidermal hyperplasia induced by repeated treatment of mouse skin with phorbol ester. AGN 190744 also is active in an arachidonic acid model of acute inflammation. These data suggest that topical application of calcium-channel antagonists can inhibit cutaneous inflammatory responses and that AGN 190742 and/or AGN 190744 may serve as useful pharmacological probes for examining these responses in vivo.</abstract><cop>United States</cop><pmid>7601508</pmid><doi>10.1007/BF01534466</doi><tpages>15</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0360-3997 |
| ispartof | Inflammation, 1995-04, Vol.19 (2), p.261-275 |
| issn | 0360-3997 1573-2576 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_16837020 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Administration, Cutaneous Animals Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - pharmacology Arachidonic Acid - secretion Arachidonic Acid - toxicity Calcium - metabolism Calcium Channel Blockers - administration & dosage Calcium Channel Blockers - pharmacology Chemotaxis, Leukocyte - drug effects Clobetasol - analogs & derivatives Clobetasol - pharmacology Ear, External Epidermis - drug effects Epidermis - pathology Female Humans Hyperplasia Inflammation Mice Neutrophils - drug effects Neutrophils - enzymology Neutrophils - secretion Nifedipine - pharmacology Peroxidase - analysis Phosphatidylinositol Diacylglycerol-Lyase Phosphodiesterase Inhibitors - pharmacology Phospholipases A - antagonists & inhibitors Phosphoric Diester Hydrolases - metabolism Pituitary Neoplasms - pathology Potassium Chloride - antagonists & inhibitors Pyrazoles - pharmacology Terpenes - pharmacology Tetradecanoylphorbol Acetate - toxicity Thyrotropin-Releasing Hormone - antagonists & inhibitors Tumor Cells, Cultured - drug effects |
| title | The antiinflammatory activity of topically applied novel calcium-channel antagonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T18%3A38%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20antiinflammatory%20activity%20of%20topically%20applied%20novel%20calcium-channel%20antagonists&rft.jtitle=Inflammation&rft.au=De%20Vries,%20G%20W&rft.date=1995-04-01&rft.volume=19&rft.issue=2&rft.spage=261&rft.epage=275&rft.pages=261-275&rft.issn=0360-3997&rft.eissn=1573-2576&rft_id=info:doi/10.1007/BF01534466&rft_dat=%3Cproquest_cross%3E16837020%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16837020&rft_id=info:pmid/7601508&rfr_iscdi=true |